These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Experiences with josamycin therapy in dermatologic diseases]. Kiss Z Orv Hetil; 2000 May; 141(19):1015-7. PubMed ID: 10846423 [TBL] [Abstract][Full Text] [Related]
7. [Criteria for the selection of antibiotics in the empirical therapy of gram negative infections]. Betts RF Internist (Berl); 1981 Nov; 22(11):710-4. PubMed ID: 7031008 [No Abstract] [Full Text] [Related]
8. [The macrolide antibiotics in treatment of skin diseases]. Owczarek W; Paluchowska E Pol Merkur Lekarski; 2008 Nov; 25(149):429-31. PubMed ID: 19177782 [TBL] [Abstract][Full Text] [Related]
9. Proceedings: Joint symposium with the skin microbiology club: Aspects of skin microbiology. Noble WC J Med Microbiol; 1975 May; 8(2):Pi-ii. PubMed ID: 1142403 [No Abstract] [Full Text] [Related]
10. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. Bradford PA; Weaver-Sands DT; Petersen PJ Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070 [TBL] [Abstract][Full Text] [Related]
11. Are the quinolones realising their clinical potential? Ball P J Chemother; 1989 Jul; 1(4 Suppl):664-5. PubMed ID: 16312582 [No Abstract] [Full Text] [Related]
12. A guide to antibiotic resistance in bacterial skin infections. Perera G; Hay R J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705 [TBL] [Abstract][Full Text] [Related]